<?xml version="1.0" encoding="utf-8"?>
<root>
  <statement>
    <name>Dieting in adolescence</name>
    <shortlink>dieting-adolescence</shortlink>
    <posted>01-Sep-04</posted>
    <Reaffirmed>28-Feb-18</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/9.7.487</DOI>
    <kwrd />
  </statement>
  <statement>
    <name>Harm reduction: An approach to reducing risky health behaviours in adolescents</name>
    <shortlink>harm-reduction-risky-health-behaviours</shortlink>
    <posted>01-Jan-08</posted>
    <Reaffirmed>28-Feb-18</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>05-Oct-18</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/13.1.53</DOI>
    <kwrd />
  </statement>
  <statement>
    <name>Management of HIV-exposed and HIV-infected children</name>
    <shortlink>HIV-exposed-and-HIV-infected-children</shortlink>
    <posted>01-Aug-10</posted>
    <Reaffirmed>28-Feb-18</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/15.6.379</DOI>
    <kwrd />
  </statement>
  <statement>
    <name>Emergency treatment of anaphylaxis in infants and children</name>
    <shortlink>emergency-treatment-anaphylaxis</shortlink>
    <posted>01-Jan-11</posted>
    <Reaffirmed>28-Feb-18</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>07-Aug-19</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/16.1.35</DOI>
    <kwrd>Anaphylaxis</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Emergency</kwrd>
    <kwrd>Infant</kwrd>
    <kwrd>Paediatric</kwrd>
    <kwrd>Treatment</kwrd>
  </statement>
  <statement>
    <name>Management of community-associated methicillin-resistant Staphylococcus aureus skin abscesses in children</name>
    <shortlink>methicillin-resistant-Staphylococcus-aureus-skin-abscesses</shortlink>
    <posted>01-Feb-11</posted>
    <Reaffirmed>01-Jan-20</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>07-Feb-20</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/16.2.115</DOI>
    <kwrd>Methicillin-resistant</kwrd>
    <kwrd>Skin abscess</kwrd>
    <kwrd>Staphylococcus aureus</kwrd>
  </statement>
  <statement>
    <name>Premedication for endotracheal intubation in the newborn infant</name>
    <shortlink>endotracheal-intubation-newborn</shortlink>
    <posted>01-Mar-11</posted>
    <Reaffirmed>28-Feb-18</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>06-Apr-18</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/16.3.159</DOI>
    <kwrd>Bradycardia</kwrd>
    <kwrd>Endotracheal intubation</kwrd>
    <kwrd>Hypertension</kwrd>
    <kwrd>Hypoxia</kwrd>
    <kwrd>Newborn</kwrd>
    <kwrd>Pain</kwrd>
    <kwrd>Premedication </kwrd>
  </statement>
  <statement>
    <name>Child and youth injury prevention: A public health approach</name>
    <shortlink>child-and-youth-injury-prevention</shortlink>
    <posted>02-Nov-12</posted>
    <Reaffirmed>01-Jan-20</Reaffirmed>
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>30-Nov-21</changed>
    <Committee>Injury Prevention Committee</Committee>
    <DOI>10.1093/pch/17.9.511</DOI>
    <kwrd>Canada</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Injury</kwrd>
    <kwrd>Prevention</kwrd>
    <kwrd>Public health</kwrd>
    <kwrd>Youth</kwrd>
  </statement>
  <statement>
    <name>The medical assessment of bruising in suspected child maltreatment cases: A clinical perspective</name>
    <shortlink>medical-assessment-of-bruising</shortlink>
    <posted>03-Oct-13</posted>
    <Reaffirmed>30-Jan-17</Reaffirmed>
    <updated>24-Mar-16</updated>
    <hasupdates>no</hasupdates>
    <changed>15-Feb-17</changed>
    <Committee>Child and Youth Maltreatment Section</Committee>
    <DOI>10.1093/pch/18.8.433</DOI>
    <kwrd>Bruise</kwrd>
    <kwrd>Bruising</kwrd>
    <kwrd>Child abuse</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Coagulopathy</kwrd>
    <kwrd>Maltreatment</kwrd>
  </statement>
  <statement>
    <name>Clostridium difficile in paediatric populations</name>
    <shortlink>clostridium-difficile-in-paediatric-populations</shortlink>
    <posted>10-Jan-14</posted>
    <Reaffirmed>24-Feb-23</Reaffirmed>
    <updated>05-Mar-20</updated>
    <hasupdates>no</hasupdates>
    <changed>24-Feb-23</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/19.1.43</DOI>
    <kwrd>CDI</kwrd>
    <kwrd>Colitis</kwrd>
    <kwrd>Diarrhea</kwrd>
    <kwrd>Immunocompromise</kwrd>
    <kwrd>Megacolon</kwrd>
    <kwrd>Metronidazole</kwrd>
    <kwrd>NAP1</kwrd>
    <kwrd>Vancomycin</kwrd>
  </statement>
  <statement>
    <name>Red blood cell transfusion in newborn infants</name>
    <shortlink>red-blood-cell-transfusion-newborn-infants</shortlink>
    <posted>04-Apr-14</posted>
    <Reaffirmed>01-Jan-20</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/19.4.213 </DOI>
    <kwrd>Anemia</kwrd>
    <kwrd>Blood grouping</kwrd>
    <kwrd>Cross-matching</kwrd>
    <kwrd>Erythrocyte</kwrd>
    <kwrd>Hemorrhagic shock</kwrd>
    <kwrd>Hyperkalemia</kwrd>
  </statement>
  <statement>
    <name>Antimicrobial stewardship in daily practice: Managing an important resource</name>
    <shortlink>antimicrobial-stewardship</shortlink>
    <posted>01-May-14</posted>
    <Reaffirmed>01-Jan-20</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/19.5.261 </DOI>
    <kwrd>AOM</kwrd>
    <kwrd>C difficile</kwrd>
    <kwrd>E coli</kwrd>
    <kwrd>Pneumonia</kwrd>
    <kwrd>Superbugs</kwrd>
    <kwrd>UTIs</kwrd>
  </statement>
  <statement>
    <name>Urinary tract infection in infants and children: Diagnosis and management</name>
    <shortlink>urinary-tract-infections-in-children</shortlink>
    <posted>13-Jun-14</posted>
    <Reaffirmed>01-Jan-20</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/19.6.315 </DOI>
    <kwrd>Bacteremia</kwrd>
    <kwrd>Cefixime</kwrd>
    <kwrd>Cystitis</kwrd>
    <kwrd>Gentamicin</kwrd>
    <kwrd>Pyelonephritis</kwrd>
    <kwrd>Pyuria</kwrd>
    <kwrd>Sepsis</kwrd>
    <kwrd>UTI</kwrd>
    <kwrd>VUR</kwrd>
  </statement>
  <statement>
    <name>Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age</name>
    <shortlink>bronchiolitis</shortlink>
    <posted>03-Nov-14</posted>
    <Reaffirmed />
    <updated>30-Nov-21</updated>
    <hasupdates>yes</hasupdates>
    <changed>30-Nov-21</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Drug Therapy Committee</Committee>
    <DOI>10.1093/pch/19.9.485 </DOI>
    <kwrd>Respiratory distress</kwrd>
    <kwrd>RSV</kwrd>
    <kwrd>URTI</kwrd>
    <kwrd>Wheezing</kwrd>
  </statement>
  <statement>
    <name>Prophylactic antibiotics for children with recurrent urinary tract infections</name>
    <shortlink>prophylactic-antibiotics-recurrent-urinary-tract-infections</shortlink>
    <posted>06-Feb-15</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>15-Mar-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>15-Mar-24</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/20.1.45</DOI>
    <kwrd>Antibiotic resistance</kwrd>
    <kwrd>Antibiotic stewardship</kwrd>
    <kwrd>Renal scarring</kwrd>
    <kwrd>UTI</kwrd>
    <kwrd>VUR</kwrd>
  </statement>
  <statement>
    <name>Managing type 1 diabetes in school: Recommendations for policy and practice</name>
    <shortlink>type-1-diabetes-in-school</shortlink>
    <posted>06-Feb-15</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Jun-21</changed>
    <Committee />
    <DOI>10.1093/pch/20.1.35</DOI>
    <kwrd>Education</kwrd>
    <kwrd>Policy</kwrd>
    <kwrd>Type 1 diabetes</kwrd>
  </statement>
  <statement>
    <name>Preventing ophthalmia neonatorum</name>
    <shortlink>ophthalmia-neonatorum</shortlink>
    <posted>06-Mar-15</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/20.2.93</DOI>
    <kwrd>Chlamydia</kwrd>
    <kwrd>Gonococcus</kwrd>
    <kwrd>Neonatal ophthalmia</kwrd>
    <kwrd>Prophylaxis</kwrd>
    <kwrd>Screening in pregnancy</kwrd>
    <kwrd>STIs</kwrd>
  </statement>
  <statement>
    <name>Ankyloglossia and breastfeeding</name>
    <shortlink>ankyloglossia-breastfeeding</shortlink>
    <posted>11-May-15</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/20.4.209</DOI>
    <kwrd>Ankyloglossia</kwrd>
    <kwrd>Breastfeeding</kwrd>
    <kwrd>Frenotomy</kwrd>
    <kwrd>Infant</kwrd>
    <kwrd>Tongue-tie</kwrd>
  </statement>
  <statement>
    <name>Suicidal ideation and behaviour</name>
    <shortlink>suicidal-ideation-and-behaviour</shortlink>
    <posted>05-Jun-15</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>03-Oct-19</updated>
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/20.5.257</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>Mental health</kwrd>
    <kwrd>Prevention</kwrd>
    <kwrd>Risk assessment</kwrd>
    <kwrd>Suicide</kwrd>
  </statement>
  <statement>
    <name>Newborn male circumcision</name>
    <shortlink>circumcision</shortlink>
    <posted>08-Sep-15</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/20.6.311</DOI>
    <kwrd>Circumcision</kwrd>
    <kwrd>HIV</kwrd>
    <kwrd>HPV</kwrd>
    <kwrd>HSV</kwrd>
    <kwrd>Infant</kwrd>
    <kwrd>STI</kwrd>
    <kwrd>UTI</kwrd>
  </statement>
  <statement>
    <name>Housing need in Canada: Healthy lives start at home</name>
    <shortlink>housing-need</shortlink>
    <posted>05-Oct-15</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>31-Oct-19</updated>
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/20.7.403</DOI>
    <kwrd>Determinants of health</kwrd>
    <kwrd>Health advocacy</kwrd>
    <kwrd>Housing</kwrd>
    <kwrd>Public health</kwrd>
    <kwrd>Social paediatrics</kwrd>
  </statement>
  <statement>
    <name>Diagnosis and management of asthma in preschoolers: A Canadian Thoracic Society and Canadian Paediatric Society position paper</name>
    <shortlink>asthma-in-preschoolers</shortlink>
    <posted>05-Oct-15</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>07-Aug-19</changed>
    <Committee />
    <DOI>10.1093/pch/20.7.353 </DOI>
    <kwrd>Asthma</kwrd>
    <kwrd>Child</kwrd>
    <kwrd>Criteria</kwrd>
    <kwrd>Diagnosis</kwrd>
    <kwrd>Disease management</kwrd>
    <kwrd>Preschool</kwrd>
    <kwrd>Therapeutic trial</kwrd>
  </statement>
  <statement>
    <name>Minimizing blood loss and the need for transfusions in very premature infants</name>
    <shortlink>minimizing-blood-loss</shortlink>
    <posted>04-Dec-15</posted>
    <Reaffirmed>01-Jan-21</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>21-Jan-21</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/20.8.451</DOI>
    <kwrd>Anemia</kwrd>
    <kwrd>Bilirubin</kwrd>
    <kwrd>Blood CO2</kwrd>
    <kwrd>Cord clamping</kwrd>
    <kwrd>Cord milking</kwrd>
    <kwrd>Erythropoietin</kwrd>
    <kwrd>RoP</kwrd>
    <kwrd>Supplementary iron</kwrd>
  </statement>
  <statement>
    <name>Management of acute otitis media in children six months of age and older</name>
    <shortlink>acute-otitis-media</shortlink>
    <posted>05-Feb-16</posted>
    <Reaffirmed>21-Nov-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/21.1.39 </DOI>
    <kwrd>AOM</kwrd>
    <kwrd>MEE</kwrd>
    <kwrd>OME</kwrd>
    <kwrd>PCV13</kwrd>
    <kwrd>TM</kwrd>
  </statement>
  <statement>
    <name>Retinopathy of prematurity: An update on screening and management</name>
    <shortlink>retinopathy-of-prematurity-screening</shortlink>
    <posted>07-Mar-16</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>07-Aug-19</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/21.2.101</DOI>
    <kwrd>Anti-VEGF therapy</kwrd>
    <kwrd>Retinopathy of prematurity</kwrd>
    <kwrd>ROP screening</kwrd>
  </statement>
  <statement>
    <name>Mental health problems in children with neuromotor disabilities</name>
    <shortlink>mental-health-problems-neuromotor-disabilities</shortlink>
    <posted>07-Mar-16</posted>
    <Reaffirmed>22-Nov-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Mar-22</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/21.2.93</DOI>
    <kwrd>CP</kwrd>
    <kwrd>Disability</kwrd>
    <kwrd>HRQOL</kwrd>
    <kwrd>ICF</kwrd>
    <kwrd>Mental health</kwrd>
    <kwrd>Spina bifida</kwrd>
  </statement>
  <statement>
    <name>Assessment of cardiorespiratory stability using the infant car seat challenge before discharge in preterm infants (&lt;37 weeks' gestational age)</name>
    <shortlink>infant-car-seat-challenge</shortlink>
    <posted>01-Apr-16</posted>
    <Reaffirmed>30-Oct-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Mar-22</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/21.3.155 </DOI>
    <kwrd>Apnea</kwrd>
    <kwrd>Bradycardia</kwrd>
    <kwrd>Desaturation</kwrd>
    <kwrd>ICSC</kwrd>
    <kwrd>Neonate</kwrd>
    <kwrd>PSG</kwrd>
  </statement>
  <statement>
    <name>Strategies to promote smoking cessation among adolescents</name>
    <shortlink>smoking-cessation</shortlink>
    <posted>10-May-16</posted>
    <Reaffirmed>29-Oct-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/21.4.201</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>CBT</kwrd>
    <kwrd>Counselling</kwrd>
    <kwrd>NRT</kwrd>
    <kwrd>Smoking cessation</kwrd>
    <kwrd>Tobacco</kwrd>
  </statement>
  <statement>
    <name>Meeting the needs of adolescent parents and their children</name>
    <shortlink>adolescent-parents</shortlink>
    <posted>06-Jun-16</posted>
    <Reaffirmed>29-Oct-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>18-Nov-16</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/21.5.273</DOI>
    <kwrd>Adolescent mothers</kwrd>
    <kwrd>Adolescent parenting</kwrd>
    <kwrd>Social determinants of health</kwrd>
    <kwrd>Social inequities</kwrd>
    <kwrd>Teen pregnancy</kwrd>
  </statement>
  <statement>
    <name>An update to the Greig Health Record: Preventive health care visits for children and adolescents aged 6 to 17 years – Technical report</name>
    <shortlink>greig-health-record-technical-report</shortlink>
    <posted>06-Jun-16</posted>
    <Reaffirmed>01-Mar-22</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Mar-22</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/21.5.265</DOI>
    <kwrd />
  </statement>
  <statement>
    <name>An update to the Greig Health Record: Executive summary</name>
    <shortlink>greig-executive-summary</shortlink>
    <posted>06-Jun-16</posted>
    <Reaffirmed>01-Mar-22</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Mar-22</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI />
    <kwrd>Adolescents</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Counselling</kwrd>
    <kwrd>Evidence-based practice</kwrd>
    <kwrd>Forms and records</kwrd>
    <kwrd>Preventive health services</kwrd>
    <kwrd>Primary prevention</kwrd>
    <kwrd>Screening</kwrd>
  </statement>
  <statement>
    <name>Caring for children and youth from Canadian military families: Special considerations</name>
    <shortlink>military-families</shortlink>
    <posted>03-May-17</posted>
    <Reaffirmed>24-Feb-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Feb-23</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/pxx021</DOI>
    <kwrd>Behaviour</kwrd>
    <kwrd>Mental health</kwrd>
    <kwrd>Military deployment</kwrd>
    <kwrd>Military families</kwrd>
    <kwrd>Stress</kwrd>
  </statement>
  <statement>
    <name>Cannabis and Canada's children and youth</name>
    <shortlink>cannabis-children-and-youth</shortlink>
    <posted>03-May-17</posted>
    <Reaffirmed>24-Feb-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Feb-23</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxx017 </DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>CUD</kwrd>
    <kwrd>CWS</kwrd>
    <kwrd>Neurodevelopment</kwrd>
    <kwrd>THC</kwrd>
    <kwrd>Youth</kwrd>
  </statement>
  <statement>
    <name>Acute management of croup in the emergency department</name>
    <shortlink>acute-management-of-croup</shortlink>
    <posted>24-May-17</posted>
    <Reaffirmed>07-Jun-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>07-Jul-23</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxx019 </DOI>
    <kwrd>Corticosteroids</kwrd>
    <kwrd>Croup</kwrd>
    <kwrd>Dexamethasone</kwrd>
    <kwrd>Epinephrine</kwrd>
    <kwrd>Heliox</kwrd>
  </statement>
  <statement>
    <name>Management of term infants at increased risk for early onset bacterial sepsis</name>
    <shortlink>management-infant-sepsis</shortlink>
    <posted>15-Jun-17</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-Nov-20</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxx023 </DOI>
    <kwrd>Chorioamnionitis</kwrd>
    <kwrd>Early-onset sepsis</kwrd>
    <kwrd>Group B streptococcus</kwrd>
    <kwrd>Newborn</kwrd>
  </statement>
  <statement>
    <name>Canada's eight-component vaccine safety system: A primer for health care workers</name>
    <shortlink>vaccine-safety-system</shortlink>
    <posted>15-Jun-17</posted>
    <Reaffirmed>24-Feb-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Feb-23</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxx073</DOI>
    <kwrd>AEFI</kwrd>
    <kwrd>BGTD</kwrd>
    <kwrd>CAEFISS</kwrd>
    <kwrd>IMPACT</kwrd>
    <kwrd>NACI</kwrd>
    <kwrd>Vaccine safety</kwrd>
  </statement>
  <statement>
    <name>The relationship between paediatric practitioners and 'industry'</name>
    <shortlink>paediatric-practitioners-and-industry</shortlink>
    <posted>11-Aug-17</posted>
    <Reaffirmed>03-Mar-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>03-Mar-23</changed>
    <Committee>Bioethics Committee</Committee>
    <DOI>10.1093/pch/pxx096</DOI>
    <kwrd>Beneficence, COI, Gifting, Non-maleficence</kwrd>
  </statement>
  <statement>
    <name>Counselling and management for anticipated extremely preterm birth</name>
    <shortlink>management-anticipated-extremely-preterm-birth</shortlink>
    <posted>11-Aug-17</posted>
    <Reaffirmed>21-Apr-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>21-Apr-23</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxx058</DOI>
    <kwrd>ANCS, Decision making, Extremely preterm infant, NDD, QOL, SDM</kwrd>
  </statement>
  <statement>
    <name>Tobacco use and misuse among Indigenous children and youth in Canada</name>
    <shortlink>tobacco-aboriginal-people</shortlink>
    <posted>06-Oct-17</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-Nov-20</changed>
    <Committee>First Nations, Inuit and Métis Health Committee</Committee>
    <DOI>10.1093/pch/pxx124 </DOI>
    <kwrd>Aboriginal</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Indigenous</kwrd>
    <kwrd>Smoking </kwrd>
    <kwrd>Tobacco</kwrd>
    <kwrd>Youth</kwrd>
  </statement>
  <statement>
    <name>Energy and sports drinks in children and adolescents</name>
    <shortlink>energy-and-sports-drinks</shortlink>
    <posted>06-Oct-17</posted>
    <Reaffirmed>24-Feb-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Feb-23</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxx132</DOI>
    <kwrd>Alcohol</kwrd>
    <kwrd>Caffeine</kwrd>
    <kwrd>CEDs</kwrd>
    <kwrd>Energy drinks</kwrd>
    <kwrd>Sports drinks</kwrd>
  </statement>
  <statement>
    <name>Screening for disruptive behaviour problems in preschool children in primary health care settings</name>
    <shortlink>disruptive-behaviour</shortlink>
    <posted>27-Nov-17</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-Nov-20</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/pxx128</DOI>
    <kwrd>ADHD</kwrd>
    <kwrd>Behaviour problems</kwrd>
    <kwrd>ODD</kwrd>
    <kwrd>Preschoolers</kwrd>
    <kwrd>Primary care</kwrd>
    <kwrd>Screening</kwrd>
  </statement>
  <statement>
    <name>Pulse oximetry screening in newborns to enhance detection of critical congenital heart disease</name>
    <shortlink>pulse-oximetry-screening</shortlink>
    <posted>27-Nov-17</posted>
    <Reaffirmed>24-Feb-23</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Feb-23</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxx136</DOI>
    <kwrd>CCHD</kwrd>
    <kwrd>NICU</kwrd>
    <kwrd>POS</kwrd>
  </statement>
  <statement>
    <name>Head lice infestations: A clinical update</name>
    <shortlink>head-lice</shortlink>
    <posted>15-Feb-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>08-Nov-23</updated>
    <hasupdates>yes</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/pxx165 </DOI>
    <kwrd>Dimeticone solution</kwrd>
    <kwrd>Head lice</kwrd>
    <kwrd>Infestations</kwrd>
    <kwrd>Isopropyl myristate/cyclomethicone solution</kwrd>
    <kwrd>Permethrin</kwrd>
    <kwrd>Pyrethrin</kwrd>
  </statement>
  <statement>
    <name>Rapid response systems for paediatrics: Suggestions for optimal organization and training</name>
    <shortlink>rapid-response-systems-for-paediatrics</shortlink>
    <posted>16-Feb-18</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxx133</DOI>
    <kwrd>Education</kwrd>
    <kwrd>Paediatric</kwrd>
    <kwrd>Rapid response teams</kwrd>
    <kwrd>Rapid response systems</kwrd>
    <kwrd>Resuscitation</kwrd>
    <kwrd>Simulation</kwrd>
    <kwrd>Team training</kwrd>
  </statement>
  <statement>
    <name>Cross-cultural communication: Tools for working with families and children</name>
    <shortlink>cross-cultural-communication</shortlink>
    <posted>16-Feb-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Global Child &amp; Youth Health Section</Committee>
    <DOI>10.1093/pch/pxx126</DOI>
    <kwrd>Communication</kwrd>
    <kwrd>Culture</kwrd>
    <kwrd>Global health</kwrd>
    <kwrd>Immigrant health</kwrd>
    <kwrd>Indigenous health</kwrd>
  </statement>
  <statement>
    <name>The medical assessment of fractures in suspected child maltreatment: Infants and young children with skeletal injury</name>
    <shortlink>fractures-in-suspected-child-maltreatment</shortlink>
    <posted>12-Apr-18</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Child and Youth Maltreatment Section</Committee>
    <DOI>10.1093/pch/pxx131</DOI>
    <kwrd>Child abuse</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Fracture</kwrd>
    <kwrd>Maltreatment</kwrd>
    <kwrd>Physical abuse</kwrd>
  </statement>
  <statement>
    <name>Medical decision-making in paediatrics: Infancy to adolescence</name>
    <shortlink>medical-decision-making-in-paediatrics-infancy-to-adolescence</shortlink>
    <posted>12-Apr-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Bioethics Committee</Committee>
    <DOI>10.1093/pch/pxx127</DOI>
    <kwrd>Advanced directives</kwrd>
    <kwrd>Best Interests</kwrd>
    <kwrd>Emancipated minors</kwrd>
    <kwrd>End-of-life</kwrd>
    <kwrd>Informed consent</kwrd>
    <kwrd>Mature minors</kwrd>
    <kwrd>SDM</kwrd>
  </statement>
  <statement>
    <name>Supporting and communicating with families experiencing a perinatal loss</name>
    <shortlink>perinatal-loss</shortlink>
    <posted>18-Apr-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxy134</DOI>
    <kwrd>Counselling</kwrd>
    <kwrd>Palliative care</kwrd>
    <kwrd>Parental grief</kwrd>
    <kwrd>Perinatal death</kwrd>
    <kwrd>Perinatal hospice</kwrd>
  </statement>
  <statement>
    <name>Determining treatment goal weights for children and adolescents with anorexia nervosa</name>
    <shortlink>goal-weights</shortlink>
    <posted>19-Apr-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxy133 </DOI>
    <kwrd>AN</kwrd>
    <kwrd>EDs</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>TGW</kwrd>
  </statement>
  <statement>
    <name>Use of high-flow nasal cannula oxygen therapy in infants and children</name>
    <shortlink>nasal-cannula</shortlink>
    <posted>09-May-18</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>12-Feb-20</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxy142 </DOI>
    <kwrd>Heated humidified high-flow nasal cannula</kwrd>
    <kwrd>Paediatric</kwrd>
  </statement>
  <statement>
    <name>Immunization of the immunocompromised child: Key principles</name>
    <shortlink>immunization-of-the-immunocompromised-child-key-principles</shortlink>
    <posted>11-May-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxx180</DOI>
    <kwrd>Immunocompromise</kwrd>
    <kwrd>Immunization</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Vaccines</kwrd>
  </statement>
  <statement>
    <name>Decision-making around gastrostomy tube feeding in children with neurologic impairment: Engaging effectively with families</name>
    <shortlink>gastrostomy-tube-feeding</shortlink>
    <posted>11-May-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Hospital Paediatrics Section</Committee>
    <DOI>10.1093/pch/pxx193 </DOI>
    <kwrd>G-tube</kwrd>
    <kwrd>ICF</kwrd>
    <kwrd>Shared decision-making</kwrd>
  </statement>
  <statement>
    <name>Hypothermia for newborns with hypoxic-ischemic encephalopathy</name>
    <shortlink>hypothermia-for-newborns</shortlink>
    <posted>12-Jun-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxy028</DOI>
    <kwrd>Hypoxic-ischemic encephalopathy</kwrd>
    <kwrd>Therapeutic hypothermia </kwrd>
  </statement>
  <statement>
    <name>Human papillomavirus vaccine for children and adolescents</name>
    <shortlink>HPV</shortlink>
    <posted>12-Jun-18</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxx179 </DOI>
    <kwrd>HPV</kwrd>
    <kwrd>Vaccine </kwrd>
  </statement>
  <statement>
    <name>Contraceptive care for Canadian youth</name>
    <shortlink>contraceptive-care</shortlink>
    <posted>12-Jun-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Jan-24</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxx192</DOI>
    <kwrd>Bone mineral density</kwrd>
    <kwrd>Contraception</kwrd>
    <kwrd>Combined oral contraception</kwrd>
    <kwrd>Emergency contraception</kwrd>
    <kwrd>Intrauterine contraception</kwrd>
    <kwrd>Long-acting reversible contraception (LARC)</kwrd>
    <kwrd>Sexual and reproductive health</kwrd>
  </statement>
  <statement>
    <name>Fever in the returning child traveller: Highlights for health care providers</name>
    <shortlink>fever-in-the-returning-child-traveller</shortlink>
    <posted>28-Jun-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>01-Dec-23</updated>
    <hasupdates>yes</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Global Child &amp; Youth Health Section</Committee>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy138</DOI>
    <kwrd>Children</kwrd>
    <kwrd>Fever</kwrd>
    <kwrd>Travel health</kwrd>
    <kwrd>Tropical disease</kwrd>
  </statement>
  <statement>
    <name>Potential strategies to improve childhood immunization rates in Canada</name>
    <shortlink>strategies-to-improve-childhood-immunization</shortlink>
    <posted>18-Jul-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>22-Jan-25</updated>
    <hasupdates>yes</hasupdates>
    <changed>24-Jan-25</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy052 </DOI>
    <kwrd>Immunization</kwrd>
    <kwrd>Immunization mandate</kwrd>
    <kwrd>Immunization programs</kwrd>
  </statement>
  <statement>
    <name>Imaging the term neonatal brain</name>
    <shortlink>imaging-the-term-neonatal-brain</shortlink>
    <posted>18-Jul-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxx161</DOI>
    <kwrd>Brain imaging</kwrd>
    <kwrd>Encephalopathy</kwrd>
    <kwrd>Newborn</kwrd>
  </statement>
  <statement>
    <name>Diagnosis and management of acute osteoarticular infections in children</name>
    <shortlink>osteoarticular-infections-in-children</shortlink>
    <posted>18-Jul-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy049</DOI>
    <kwrd>Acute osteomyelitis</kwrd>
    <kwrd>C-reactive protein test</kwrd>
    <kwrd>Methicillin-resistant Staphylococcus aureus</kwrd>
    <kwrd>Methicillin-susceptible Staphylococcus aureus</kwrd>
    <kwrd>Septic arthritis</kwrd>
  </statement>
  <statement>
    <name>Stinging insect hypersensitivity: Evaluation and management in children and youth</name>
    <shortlink>stinging-insect-hypersensitivity</shortlink>
    <posted>01-Aug-18</posted>
    <Reaffirmed></Reaffirmed>
    <updated>11-Apr-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>11-Apr-24</changed>
    <Committee>Allergy Section</Committee>
    <DOI>10.1093/pch/pxy140</DOI>
    <kwrd>Allergy</kwrd>
    <kwrd>Anaphylaxis</kwrd>
    <kwrd>Large local reaction</kwrd>
    <kwrd>Stinging insect</kwrd>
    <kwrd>Venom immunotherapy</kwrd>
  </statement>
  <statement>
    <name>Guidelines for vitamin K prophylaxis in newborns</name>
    <shortlink>vitamin-k-prophylaxis-in-newborns</shortlink>
    <posted>16-Aug-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxy082</DOI>
    <kwrd>HDNB</kwrd>
    <kwrd>Newborn</kwrd>
    <kwrd>Prophylaxis</kwrd>
    <kwrd>Vitamin K</kwrd>
    <kwrd>VKDB</kwrd>
  </statement>
  <statement>
    <name>Evaluation of the child with global developmental delay and intellectual disability</name>
    <shortlink>evaluation-of-the-child-with-global-developmental-delay-and-intellectual-disability</shortlink>
    <posted>16-Aug-18</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/pxy093</DOI>
    <kwrd>Chromosome microarray</kwrd>
    <kwrd>Global developmental delay</kwrd>
    <kwrd>Intellectual disability</kwrd>
    <kwrd>IEM</kwrd>
  </statement>
  <statement>
    <name>Working with vaccine-hesitant parents: An update</name>
    <shortlink>working-with-vaccine-hesitant-parents</shortlink>
    <posted>14-Sep-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>19-Oct-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>14-Nov-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy144</DOI>
    <kwrd>Health care workers</kwrd>
    <kwrd>Health communication</kwrd>
    <kwrd>Pain on immunization</kwrd>
    <kwrd>Vaccine acceptance</kwrd>
    <kwrd>Vaccine hesitancy</kwrd>
    <kwrd>Vaccine refusal</kwrd>
  </statement>
  <statement>
    <name>Addressing vaccine hesitancy in immunization programs, clinics and practices</name>
    <shortlink>vaccine-hesitancy-in-immunization-programs</shortlink>
    <posted>14-Sep-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>23-May-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>27-May-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy131 </DOI>
    <kwrd>Health communication</kwrd>
    <kwrd>Vaccine acceptance</kwrd>
    <kwrd>Vaccine education</kwrd>
    <kwrd>Vaccine hesitancy</kwrd>
    <kwrd>vaccine uptake</kwrd>
  </statement>
  <statement>
    <name>The use of antiviral drugs for influenza: Guidance for practitioners</name>
    <shortlink>antiviral-drugs-for-influenza</shortlink>
    <posted>09-Oct-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy148</DOI>
    <kwrd>Antiviral therapy</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Influenza</kwrd>
    <kwrd>Neuraminidase inhibitors</kwrd>
  </statement>
  <statement>
    <name>ADHD in children and youth: Part 1—Etiology, diagnosis, and comorbidity</name>
    <shortlink>adhd-etiology-diagnosis-and-comorbidity</shortlink>
    <posted>24-Oct-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/pxy109</DOI>
    <kwrd>Attention-deficit hyperactivity disorder</kwrd>
    <kwrd>Comorbidity</kwrd>
    <kwrd>Diagnosis</kwrd>
    <kwrd>Etiology</kwrd>
  </statement>
  <statement>
    <name>ADHD in children and youth: Part 2—Treatment</name>
    <shortlink>adhd-2-treatment</shortlink>
    <posted>24-Oct-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/pxy113</DOI>
    <kwrd>ADHD</kwrd>
    <kwrd>Adverse effects</kwrd>
    <kwrd>Combined interventions</kwrd>
    <kwrd>Medication management</kwrd>
  </statement>
  <statement>
    <name>ADHD in children and youth: Part 3—Assessment and treatment with comorbid ASD, ID, or prematurity</name>
    <shortlink>adhd-comorbid-asd-id-or-prematurity</shortlink>
    <posted>24-Oct-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/pxy111</DOI>
    <kwrd>Autism</kwrd>
    <kwrd>ADHD</kwrd>
    <kwrd>Intellectual disability</kwrd>
    <kwrd>Prematurity</kwrd>
  </statement>
  <statement>
    <name>Diagnosis and management of typical, newly diagnosed primary immune thrombocytopenia (ITP) of childhood</name>
    <shortlink>immune-thrombocytopenia</shortlink>
    <posted>26-Oct-18</posted>
    <Reaffirmed />
    <updated>21-Apr-20</updated>
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxy197</DOI>
    <kwrd>Intracranial hemorrhage (ICH)</kwrd>
    <kwrd>Immune thrombocytopenia (ITP)</kwrd>
    <kwrd>Intravenous immunoglobulin (IVIG)</kwrd>
    <kwrd>Shared decision-making (SDM)</kwrd>
  </statement>
  <statement>
    <name>Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management</name>
    <shortlink>pneumonia-management-children-youth</shortlink>
    <posted>31-Oct-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>14-Mar-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>14-Mar-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/20.8.441</DOI>
    <kwrd>Antimicrobial therapy</kwrd>
    <kwrd>Bacterial pneumonia</kwrd>
    <kwrd>Viral pneumonia</kwrd>
  </statement>
  <statement>
    <name>Needle stick injuries in the community</name>
    <shortlink>needle-stick-injuries-in-the-community</shortlink>
    <posted>19-Nov-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>14-Mar-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>27-May-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy129</DOI>
    <kwrd>Antiretrovirals</kwrd>
    <kwrd>Blood-borne infections</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Needle-stick injuries</kwrd>
  </statement>
  <statement>
    <name>Infection prevention and control in paediatric office settings</name>
    <shortlink>infection-prevention-and-control-in-paediatric-office-settings</shortlink>
    <posted>19-Nov-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy117</DOI>
    <kwrd>Ambulatory</kwrd>
    <kwrd>Infection control</kwrd>
    <kwrd>Infection transmission</kwrd>
    <kwrd>Paediatric office</kwrd>
  </statement>
  <statement>
    <name>Facilitating discharge from hospital of the healthy term infant</name>
    <shortlink>facilitating-discharge-from-hospital-of-the-healthy-term-infant</shortlink>
    <posted>19-Nov-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>11-Jan-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxy127</DOI>
    <kwrd>Hospital discharge</kwrd>
    <kwrd>Newborn</kwrd>
    <kwrd>Postpartum care</kwrd>
  </statement>
  <statement>
    <name>Salmonella infections in Canadian children</name>
    <shortlink>salmonella-infections-in-canadian-children</shortlink>
    <posted>03-Dec-18</posted>
    <Reaffirmed>21-Nov-24</Reaffirmed>
    <updated>01-Dec-2023</updated>
    <hasupdates>yes</hasupdates>
    <changed>04-Dec-2023</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy199</DOI>
    <kwrd>Non-typhoidal Salmonella</kwrd>
    <kwrd>Typhoid/paratyphoid fever</kwrd>
  </statement>
  <statement>
    <name>Approaches to detecting tuberculosis in children and youth</name>
    <shortlink>approaches-to-detecting-tuberculosis-in-children-and-youth</shortlink>
    <posted>14-Dec-18</posted>
    <Reaffirmed>11-Jan-24</Reaffirmed>
    <updated>16-Jul-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>16-Jul-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxy201</DOI>
    <kwrd>Bacille-Calmette-Guérin</kwrd>
    <kwrd>Break of contact</kwrd>
    <kwrd>Latent tuberculosis infection</kwrd>
    <kwrd>Mycobacterium tuberculosis</kwrd>
    <kwrd>Tuberculosis</kwrd>
  </statement>
  <statement>
    <name>Risk of acute hyponatremia in hospitalized children and youth receiving maintenance intravenous fluids</name>
    <shortlink>acute-hyponatremia-in-hospitalized-children-and-youth</shortlink>
    <posted>18-Dec-18</posted>
    <Reaffirmed />
    <updated>15-Jul-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>14-Jan-25</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/18.2.102</DOI>
    <kwrd>Acute hyponatremia</kwrd>
    <kwrd>Intravenous fluid prescription</kwrd>
    <kwrd>Maintenance intravenous fluids</kwrd>
  </statement>
  <statement>
    <name>Paediatric complicated pneumonia: Diagnosis and management of empyema</name>
    <shortlink>complicated-pneumonia-empyema</shortlink>
    <posted>18-Dec-18</posted>
    <Reaffirmed></Reaffirmed>
    <updated>25-May-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>27-Jun-24</changed>
    <Committee>Hospital Paediatrics Section</Committee>
    <DOI>10.1093/pch/16.7.425</DOI>
    <kwrd>Chest tube</kwrd>
    <kwrd>Complicated pneumonia</kwrd>
    <kwrd>Empyema</kwrd>
    <kwrd>Fibrinolytics</kwrd>
    <kwrd>Paediatric</kwrd>
  </statement>
  <statement>
    <name>Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children</name>
    <shortlink>oral-ondansetron</shortlink>
    <posted>19-Dec-18</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>05-May-21</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/16.3.177 </DOI>
    <kwrd>Children</kwrd>
    <kwrd>Emergency</kwrd>
    <kwrd>Gastroenteritis</kwrd>
    <kwrd>Infants</kwrd>
    <kwrd>Ondansetron</kwrd>
    <kwrd>Vomiting</kwrd>
  </statement>
  <statement>
    <name>A case-based update of PALS: Paediatric basic and advanced life-support guidelines</name>
    <shortlink>paediatric-basic-advanced-life-support</shortlink>
    <posted>19-Dec-18</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>05-May-21</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI />
    <kwrd />
  </statement>
  <statement>
    <name>Timing of introduction of allergenic solids for infants at high risk</name>
    <shortlink>allergenic-solids</shortlink>
    <posted>24-Jan-19</posted>
    <Reaffirmed />
    <updated>19-Feb-20</updated>
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Allergy Section</Committee>
    <DOI>10.1093/pch/pxy195 </DOI>
    <kwrd>Allergy prevention</kwrd>
    <kwrd>Eczema</kwrd>
    <kwrd>Food allergy</kwrd>
  </statement>
  <statement>
    <name>Invasive group A streptococcal disease: Management and chemoprophylaxis</name>
    <shortlink>invasive-group-a-streptococcal-disease</shortlink>
    <posted>15-Apr-19</posted>
    <Reaffirmed>21-Nov-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxz039 </DOI>
    <kwrd>Chemoprophylaxis</kwrd>
    <kwrd>Group A streptococcus</kwrd>
    <kwrd>Necrotizing fasciitis</kwrd>
    <kwrd>Toxic shock</kwrd>
  </statement>
  <statement>
    <name>Universal access to no-cost contraception for youth in Canada</name>
    <shortlink>universal-access-to-no-cost-contraception-for-youth-in-canada</shortlink>
    <posted>15-May-19</posted>
    <Reaffirmed>29-Oct-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>09-Nov-20</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxz033</DOI>
    <kwrd>Adolescent</kwrd>
    <kwrd>Contraception</kwrd>
    <kwrd>Health insurance</kwrd>
    <kwrd>Universal coverage</kwrd>
    <kwrd>Young adult</kwrd>
  </statement>
  <statement>
    <name>Digital media: Promoting healthy screen use in school-aged children and adolescents</name>
    <shortlink>digital-media</shortlink>
    <posted>06-Jun-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Digital Health Task Force</Committee>
    <DOI>10.1093/pch/pxz095</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Development</kwrd>
    <kwrd>Digital media</kwrd>
    <kwrd>Family</kwrd>
    <kwrd>Health</kwrd>
    <kwrd>Screen use</kwrd>
  </statement>
  <statement>
    <name>Antifungal agents for common outpatient paediatric infections</name>
    <shortlink>antifungal-agents-common-infections</shortlink>
    <posted>20-Jun-19</posted>
    <Reaffirmed>21-Nov-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>06-Apr-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/12.10.875</DOI>
    <kwrd />
  </statement>
  <statement>
    <name>Safe living strategies for the immunocompromised child</name>
    <shortlink>immunocompromised-child</shortlink>
    <posted>21-Jun-19</posted>
    <Reaffirmed>21-Nov-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxz082 </DOI>
    <kwrd>Hygiene</kwrd>
    <kwrd>Immunocompromise</kwrd>
    <kwrd>Safety</kwrd>
    <kwrd>Vaccines</kwrd>
  </statement>
  <statement>
    <name>Neuroprotection from acute brain injury in preterm infants</name>
    <shortlink>neuroprotection</shortlink>
    <posted>21-Jun-19</posted>
    <Reaffirmed>30-Oct-24</Reaffirmed>
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>09-Nov-20</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxz056</DOI>
    <kwrd>Acute brain injury</kwrd>
    <kwrd>Infant</kwrd>
    <kwrd>Intraventricular hemorrhage</kwrd>
    <kwrd>Neuroprotection</kwrd>
    <kwrd>Neuroprotective strategies</kwrd>
    <kwrd>Premature</kwrd>
  </statement>
  <statement>
    <name>Lead toxicity with a new focus: Addressing low-level lead exposure in Canadian children</name>
    <shortlink>lead-toxicity</shortlink>
    <posted>21-Jun-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Paediatric Environmental Health Section</Committee>
    <DOI>10.1093/pch/pxz080 </DOI>
    <kwrd>Blood lead levels</kwrd>
    <kwrd>Cognitive deficit</kwrd>
    <kwrd>Lead exposures</kwrd>
    <kwrd>Lead toxicity</kwrd>
    <kwrd>Paediatrics</kwrd>
  </statement>
  <statement>
    <name>Relationships matter: How clinicians can support positive parenting in the early years</name>
    <shortlink>positive-parenting</shortlink>
    <posted>25-Jul-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>08-Mar-21</changed>
    <Committee>Early Years Task Force</Committee>
    <DOI>10.1093/pch/pxz063</DOI>
    <kwrd>ACEs</kwrd>
    <kwrd>Adverse childhood experiences</kwrd>
    <kwrd>Attachment</kwrd>
    <kwrd>Parenting</kwrd>
  </statement>
  <statement>
    <name>Improving paediatric medications: A prescription for Canadian children and youth</name>
    <shortlink>improving-paediatric-medications</shortlink>
    <posted>25-Jul-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee />
    <DOI>10.1093/pch/pxz079</DOI>
    <kwrd>Health Canada</kwrd>
    <kwrd>Medications</kwrd>
    <kwrd>Paediatric formulations</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Regulation</kwrd>
    <kwrd>Research</kwrd>
  </statement>
  <statement>
    <name>Global climate change and health in Canadian children</name>
    <shortlink>global-climate-change</shortlink>
    <posted>14-Aug-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Paediatric Environmental Health Section</Committee>
    <DOI>10.1093/pch/pxz157</DOI>
    <kwrd>Canada</kwrd>
    <kwrd>Child heath</kwrd>
    <kwrd>Climate change</kwrd>
  </statement>
  <statement>
    <name>Pharmacare in Canada: The Paediatric Perspective</name>
    <shortlink>pharmacare</shortlink>
    <posted>26-Sep-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Paediatric Drugs and Therapeutics Task Force</Committee>
    <DOI>10.1093/pch/pxz176 </DOI>
    <kwrd>Pharmacare</kwrd>
    <kwrd>Paediatric Pharmaceuticals</kwrd>
    <kwrd>Drug Insurance</kwrd>
    <kwrd>Pharmaceutical Economics</kwrd>
    <kwrd>Drug Costs</kwrd>
    <kwrd>Child Health Services </kwrd>
  </statement>
  <statement>
    <name>Standards of diagnostic assessment for autism spectrum disorder</name>
    <shortlink>asd-diagnostic-assessment</shortlink>
    <posted>24-Oct-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Autism Spectrum Disorder Guidelines Task Force</Committee>
    <DOI>10.1093/pch/pxz117</DOI>
    <kwrd>Autism spectrum disorder</kwrd>
    <kwrd>Diagnostic evaluation</kwrd>
    <kwrd>Intervention planning</kwrd>
  </statement>
  <statement>
    <name>Post-diagnostic management and follow-up care for autism spectrum disorder</name>
    <shortlink>asd-post-diagnostic-management</shortlink>
    <posted>24-Oct-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Autism Spectrum Disorder Guidelines Task Force</Committee>
    <DOI>10.1093/pch/pxz121</DOI>
    <kwrd>Autism spectrum disorder</kwrd>
    <kwrd>Behavioural interventions</kwrd>
    <kwrd>Complementary and alternative medicine</kwrd>
    <kwrd>Developmental interventions</kwrd>
    <kwrd>Pharmacological management</kwrd>
  </statement>
  <statement>
    <name>Early detection for autism spectrum disorder in young children</name>
    <shortlink>asd-early-detection</shortlink>
    <posted>24-Oct-19</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Autism Spectrum Disorder Guidelines Task Force</Committee>
    <DOI>10.1093/pch/pxz119</DOI>
    <kwrd>Autism spectrum disorder</kwrd>
    <kwrd>Developmental surveillance</kwrd>
    <kwrd>Early identification</kwrd>
    <kwrd>Screening</kwrd>
  </statement>
  <statement>
    <name>Managing pain and distress in children undergoing brief diagnostic and therapeutic procedures</name>
    <shortlink>managing-pain-and-distress</shortlink>
    <posted>01-Nov-19</posted>
    <Reaffirmed>29-Oct-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Hospital Paediatrics Section</Committee>
    <Committee>Community Paediatrics Section</Committee>
    <Committee>Paediatric Emergency Medicine Section</Committee>
    <DOI>10.1093/pch/pxz026</DOI>
    <kwrd>Distress</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Pain</kwrd>
    <kwrd>Procedures</kwrd>
    <kwrd>Treatment</kwrd>
  </statement>
  <statement>
    <name>Preventing and treating infections in children with asplenia or hyposplenia</name>
    <shortlink>preventing-treating-infections-in-children-with-asplenia</shortlink>
    <posted>06-Nov-19</posted>
    <Reaffirmed>21-Nov-24</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>27-May-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/19.5.271</DOI>
    <kwrd>Antibiotic prophylaxis</kwrd>
    <kwrd>Immunization</kwrd>
    <kwrd>Sepsis</kwrd>
    <kwrd>Splenectomy</kwrd>
  </statement>
  <statement>
    <name>The screening and management of newborns at risk for low blood glucose</name>
    <shortlink>newborns-at-risk-for-low-blood-glucose</shortlink>
    <posted>20-Nov-19</posted>
    <Reaffirmed>30-Oct-24</Reaffirmed>
    <updated>28-Mar-25</updated>
    <hasupdates>yes</hasupdates>
    <changed>28-Mar-25</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxz134 </DOI>
    <kwrd>Dextrose gel</kwrd>
    <kwrd>Hypoglycemia</kwrd>
    <kwrd>Newborn</kwrd>
    <kwrd>Point-of-care</kwrd>
  </statement>
  <statement>
    <name>Iron requirements in the first 2 years of life</name>
    <shortlink>iron-requirements</shortlink>
    <posted>20-Nov-19</posted>
    <Reaffirmed>26-Mar-25</Reaffirmed>
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxz148 </DOI>
    <kwrd>Anemia</kwrd>
    <kwrd>Complementary feeding</kwrd>
    <kwrd>Infant nutrition</kwrd>
    <kwrd>Iron deficiency</kwrd>
    <kwrd>Iron requirements</kwrd>
  </statement>
  <statement>
    <name>Tuberculosis among First Nations, Inuit and Métis children and youth in Canada: Beyond medical management</name>
    <shortlink>tuberculosis-among-first-nations-inuit-and-metis-children-and-youth</shortlink>
    <posted>14-Jan-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>First Nations, Inuit and Métis Health Committee</Committee>
    <DOI>10.1093/pch/pxz183</DOI>
    <kwrd>First Nations</kwrd>
    <kwrd>Inuit</kwrd>
    <kwrd>Métis</kwrd>
    <kwrd>Indigenous</kwrd>
    <kwrd>child health</kwrd>
    <kwrd>tuberculosis</kwrd>
    <kwrd>LTBI</kwrd>
    <kwrd>social determinants</kwrd>
  </statement>
  <statement>
    <name>School nutrition: Support for providing healthy food and beverage choices in schools</name>
    <shortlink>school-nutrition-support</shortlink>
    <posted>30-Jan-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxz102</DOI>
    <kwrd>Comprehensive school health</kwrd>
    <kwrd>School nutrition policy</kwrd>
    <kwrd>Sugar-sweetened beverages</kwrd>
  </statement>
  <statement>
    <name>Dietary intake of sodium by children: Why it matters</name>
    <shortlink>dietary-intake-of-sodium-by-children</shortlink>
    <posted>30-Jan-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Mar-21</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <Committee>Drug Therapy Committee</Committee>
    <DOI>10.1093/pch/pxz153</DOI>
    <kwrd>Blood pressure</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Diet</kwrd>
    <kwrd>Hypertension</kwrd>
    <kwrd>Nutrition</kwrd>
    <kwrd>Preventive health</kwrd>
    <kwrd>Salt</kwrd>
    <kwrd>Sodium</kwrd>
  </statement>
  <statement>
    <name>Beta-lactam allergy in the paediatric population</name>
    <shortlink>beta-lactam-allergy</shortlink>
    <posted>30-Jan-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Allergy Section</Committee>
    <DOI>10.1093/pch/pxz179 </DOI>
    <kwrd>Beta-lactam</kwrd>
    <kwrd>Challenge</kwrd>
    <kwrd>Drug allergy</kwrd>
    <kwrd>Penicillin</kwrd>
  </statement>
  <statement>
    <name>A proposal to increase taxes on sugar-sweetened beverages in Canada</name>
    <shortlink>tax-on-sugar-sweetened-beverages</shortlink>
    <posted>30-Jan-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>04-Nov-20</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI />
    <kwrd>Obesity</kwrd>
    <kwrd>Overweight</kwrd>
    <kwrd>Sugar sweetened beverages</kwrd>
    <kwrd>Taxation</kwrd>
  </statement>
  <statement>
    <name>Prevention and management of neonatal herpes simplex virus infections</name>
    <shortlink>prevention-management-neonatal-herpes-simplex-virus-infections</shortlink>
    <posted>06-Mar-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>27-May-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/19.4.201</DOI>
    <kwrd>Acyclovir</kwrd>
    <kwrd>CNS</kwrd>
    <kwrd>Encephalitis</kwrd>
    <kwrd>SEM</kwrd>
    <kwrd>Sepsis</kwrd>
  </statement>
  <statement>
    <name>Nutritional evaluation of the neurologically impaired child</name>
    <shortlink>nutritional-evaluation-of-the-neurologically-impaired-child</shortlink>
    <posted>13-Mar-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxz174 </DOI>
    <kwrd>Assessment</kwrd>
    <kwrd> Neurological impairment, Nutrition</kwrd>
    <kwrd>Screening</kwrd>
  </statement>
  <statement>
    <name>Paediatric asthma and COVID-19</name>
    <shortlink>paediatric-asthma-and-covid-19</shortlink>
    <posted>01-Apr-20</posted>
    <Reaffirmed />
    <updated>08-Sep-20</updated>
    <hasupdates>no</hasupdates>
    <changed>08-Sep-20</changed>
    <Committee>Allergy Section</Committee>
    <Committee>Drug Therapy Committee</Committee>
    <Committee>Respiratory Health Section</Committee>
    <DOI />
    <kwrd />
  </statement>
  <statement>
    <name>The medical evaluation of pre-pubertal children with suspected sexual abuse</name>
    <shortlink>the-medical-evaluation-of-pre-pubertal-children-with-suspected-sexual-abuse</shortlink>
    <posted>14-Apr-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Child and Youth Maltreatment Section</Committee>
    <DOI>10.1093/pch/pxaa019 </DOI>
    <kwrd>Ano-genital examination</kwrd>
    <kwrd>Child protection</kwrd>
    <kwrd>Child sexual abuse</kwrd>
    <kwrd>Forensic evidence</kwrd>
    <kwrd>Sexually transmitted infections</kwrd>
  </statement>
  <statement>
    <name>Counselling adolescents and parents about cannabis: A primer for health professionals</name>
    <shortlink>counselling-adolescents-parents-about-cannabis-primer-for-health-professionals</shortlink>
    <posted>04-Jun-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-Feb-21</changed>
    <Committee>Cannabis Project Advisory Group</Committee>
    <DOI>10.1093/pch/pxaa048</DOI>
    <kwrd>Adolescents, cannabis, counselling, harm reduction, screening</kwrd>
  </statement>
  <statement>
    <name>The role of dietary fibre and prebiotics in the paediatric diet</name>
    <shortlink>the-role-of-dietary-fibre-and-prebiotics-in-the-paediatric-diet</shortlink>
    <posted>09-Jun-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>09-Nov-20</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxaa032 </DOI>
    <kwrd>Children</kwrd>
    <kwrd>Dietary fibre</kwrd>
    <kwrd>Microbiome</kwrd>
    <kwrd>Prebiotics</kwrd>
  </statement>
  <statement>
    <name>Routine imaging of the preterm neonatal brain</name>
    <shortlink>routine-imaging-of-preterm-neonatal-brain</shortlink>
    <posted>09-Jun-20</posted>
    <Reaffirmed />
    <updated>06-Oct-20</updated>
    <hasupdates>no</hasupdates>
    <changed>27-May-21</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI />
    <kwrd>Computed tomography (CT)</kwrd>
    <kwrd>Germinal matrix hemorrhage (GMH)</kwrd>
    <kwrd>Head ultrasound (HUS)</kwrd>
    <kwrd>Intraventricular hemorrhage (IVH)</kwrd>
    <kwrd>Magnetic resonance imaging (MRI)</kwrd>
    <kwrd>Periventricular hemorrhagic infarction (PVHI)</kwrd>
    <kwrd>Periventricular leukomalacia (PVL)</kwrd>
    <kwrd>Post-hemorrhagic ventricular dilation (PHVD)</kwrd>
  </statement>
  <statement>
    <name>Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (spring 2021 update)</name>
    <shortlink>pims</shortlink>
    <posted>06-Jul-20</posted>
    <Reaffirmed />
    <updated>03-May-21</updated>
    <hasupdates>no</hasupdates>
    <changed>14-Jul-21</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxaa033</DOI>
    <kwrd />
  </statement>
  <statement>
    <name>Lyme disease in Canada: Focus on children</name>
    <shortlink>lyme-disease-children</shortlink>
    <posted>28-Jul-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>27-May-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/19.7.379</DOI>
    <kwrd>Black-legged tick</kwrd>
    <kwrd>Borrelia burgdorferi</kwrd>
    <kwrd>Erythema migrans</kwrd>
    <kwrd>Post-treatment Lyme disease syndrome</kwrd>
  </statement>
  <statement>
    <name>Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants</name>
    <shortlink>postnatal-corticosteroids-to-prevent-or-treat-bronchopulmonary-dysplasia-in-preterm-infants</shortlink>
    <posted>31-Jul-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Nov-20</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxaa073</DOI>
    <kwrd>Bronchopulmonary dysplasia (BPD)</kwrd>
    <kwrd>Dexamethasone</kwrd>
    <kwrd>Hydrocortisone</kwrd>
    <kwrd>Inhaled corticosteroids</kwrd>
    <kwrd>Postnatal corticosteroids</kwrd>
    <kwrd>Preterm infants</kwrd>
  </statement>
  <statement>
    <name>Diagnosis and management of sepsis in the paediatric patient</name>
    <shortlink>diagnosis-and-management-of-sepsis-in-the-paediatric-patient</shortlink>
    <posted>26-Aug-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>03-Nov-20</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxz178</DOI>
    <kwrd>Guidelines</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Sepsis</kwrd>
    <kwrd>Vasoactive medications</kwrd>
    <kwrd>Volume resuscitation</kwrd>
  </statement>
  <statement>
    <name>Update on congenital cytomegalovirus infection: Prenatal prevention, newborn diagnosis, and management</name>
    <shortlink>update-on-congenital-cytomegalovirus-infection-prenatal-prevention-newborn-diagnosis-and-management</shortlink>
    <posted>09-Sep-20</posted>
    <Reaffirmed />
    <updated>24-Jan-25</updated>
    <hasupdates>yes</hasupdates>
    <changed>24-Jan-25</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxaa083</DOI>
    <kwrd>Congenital infection</kwrd>
    <kwrd>Cytomegalovirus (CMV)</kwrd>
    <kwrd>Neurodevelopmental sequelae</kwrd>
    <kwrd>Polymerase chain reaction (PCR)</kwrd>
    <kwrd>Sensorineural hearing loss (SNHL)</kwrd>
    <kwrd>Valganciclovir</kwrd>
  </statement>
  <statement>
    <name>Comprehensive care of the ambulatory child with cerebral palsy (GMFCS I and II): A Canadian perspective</name>
    <shortlink>comprehensive-care-of-the-ambulatory-child-with-cerebral-palsy-gmfcs-i-and-ii-a-canadian-perspective</shortlink>
    <posted>09-Sep-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-Dec-20</changed>
    <Committee>Developmental Paediatrics Section</Committee>
    <DOI>10.1093/pch/pxaa100</DOI>
    <kwrd>Anticipatory guidance</kwrd>
    <kwrd>Cerebral palsy</kwrd>
    <kwrd>Wellness</kwrd>
  </statement>
  <statement>
    <name>Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than 2 months of age</name>
    <shortlink>management-of-bacterial-meningitis</shortlink>
    <posted>19-Oct-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>27-May-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/19.3.141 </DOI>
    <kwrd>Ampicillin</kwrd>
    <kwrd>Antimicrobial resistance</kwrd>
    <kwrd>Cephalosporin</kwrd>
    <kwrd>Corticosteroids</kwrd>
    <kwrd>Meningitis</kwrd>
    <kwrd>PCV13</kwrd>
    <kwrd>Vancomycin</kwrd>
  </statement>
  <statement>
    <name>Medication safety for children with medical complexity</name>
    <shortlink>medication-safety-for-children-with-medical-complexity</shortlink>
    <posted>20-Oct-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>03-Nov-20</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/pxaa105 </DOI>
    <kwrd>Adverse drug events</kwrd>
    <kwrd>Children with medical complexity</kwrd>
    <kwrd>Medication</kwrd>
    <kwrd>Safety</kwrd>
  </statement>
  <statement>
    <name>Comprehensive sexual health assessments for adolescents</name>
    <shortlink>comprehensive-sexual-health-assessments-for-adolescents</shortlink>
    <posted>07-Dec-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>12-Feb-21</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxaa122 </DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>Sexual and reproductive health</kwrd>
    <kwrd>Sexually transmitted infections</kwrd>
    <kwrd>Teens</kwrd>
  </statement>
  <statement>
    <name>Pasteurized and unpasteurized donor human milk</name>
    <shortlink>pasteurized-and-unpasteurized-donor-human-milk</shortlink>
    <posted>10-Dec-20</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>17-Dec-20</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxaa118 </DOI>
    <kwrd>Breast milk</kwrd>
    <kwrd>Donor milk</kwrd>
    <kwrd>Human milk</kwrd>
    <kwrd>Milk sharing</kwrd>
  </statement>
  <statement>
    <name>Read, Speak, Sing: Promoting early literacy in the health care setting</name>
    <shortlink>read-speak-sing-promoting-literacy</shortlink>
    <posted>27-Jan-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>28-Apr-21</changed>
    <Committee>Early Years Task Force</Committee>
    <DOI>10.1093/pch/pxab005</DOI>
    <kwrd>Language</kwrd>
    <kwrd>Literacy</kwrd>
    <kwrd>Music</kwrd>
    <kwrd>Shared reading</kwrd>
    <kwrd>Song</kwrd>
    <kwrd>Storytelling</kwrd>
  </statement>
  <statement>
    <name>Guidelines for surfactant replacement therapy in neonates</name>
    <shortlink>guidelines-for-surfactant-replacement-therapy-in-neonates</shortlink>
    <posted>01-Feb-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxaa116</DOI>
    <kwrd>Bronchopulmonary dysplasia</kwrd>
    <kwrd>Neonates</kwrd>
    <kwrd>Non-invasive ventilation</kwrd>
    <kwrd>Preterm infants</kwrd>
    <kwrd>Respiratory distress syndrome</kwrd>
    <kwrd>Surfactant</kwrd>
  </statement>
  <statement>
    <name>Emergency management of the paediatric patient with convulsive status epilepticus</name>
    <shortlink>emergency-management-of-the-paediatric-patient-with-convulsive-status-epilepticus</shortlink>
    <posted>01-Feb-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>02-Feb-21</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxaa127</DOI>
    <kwrd>Convulsions</kwrd>
    <kwrd>Emergency management</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Seizures</kwrd>
    <kwrd>Status epilepticus</kwrd>
  </statement>
  <statement>
    <name>The use of oral opioids to control children's pain in the post-codeine era</name>
    <shortlink>the-use-of-oral-opioids-to-control-childrens-pain-in-the-post-codeine-era</shortlink>
    <posted>12-Mar-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>17-Mar-21</changed>
    <Committee>Drug Therapy Committee</Committee>
    <DOI>10.1093/pch/pxaa133</DOI>
    <kwrd>Hydromorphone</kwrd>
    <kwrd>Morphine</kwrd>
    <kwrd>Oxycodone</kwrd>
    <kwrd>Tramadol</kwrd>
  </statement>
  <statement>
    <name>Recommendations for procedural sedation in infants, children, and adolescents</name>
    <shortlink>recommendations-for-procedural-sedation-in-infants-children-and-adolescents</shortlink>
    <posted>12-Mar-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>22-Mar-21</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Drug Therapy Committee</Committee>
    <DOI>10.1093/pch/pxaa139 </DOI>
    <kwrd>Adverse event</kwrd>
    <kwrd>Analgesia</kwrd>
    <kwrd>Procedural sedation</kwrd>
  </statement>
  <statement>
    <name>Protecting children and adolescents against the risks of vaping</name>
    <shortlink>protecting-children-and-adolescents-against-the-risks-of-vaping</shortlink>
    <posted>14-Apr-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Mar-22</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxab037</DOI>
    <kwrd>Adolescent</kwrd>
    <kwrd>Cannabis</kwrd>
    <kwrd>Injury</kwrd>
    <kwrd>Nicotine</kwrd>
    <kwrd>Substance use</kwrd>
    <kwrd>Vaping</kwrd>
  </statement>
  <statement>
    <name>Non-IgE-mediated food allergy: Evaluation and management</name>
    <shortlink>non-ige-mediated-food-allergy-evaluation-and-management</shortlink>
    <posted>27-Apr-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>03-Jun-21</changed>
    <Committee>Allergy Section</Committee>
    <DOI>10.1093/pch/pxaa131</DOI>
    <kwrd>Allergy</kwrd>
    <kwrd>Food allergy</kwrd>
    <kwrd>Food protein-induced enterocolitis syndrome</kwrd>
    <kwrd>Food protein-induced allergic proctocolitis</kwrd>
  </statement>
  <statement>
    <name>Early Childhood Caries in Indigenous Communities</name>
    <shortlink>early-childhood-caries</shortlink>
    <posted>18-May-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>15-Jun-21</changed>
    <Committee>First Nations, Inuit and Métis Health Committee</Committee>
    <DOI>10.1093/pch/pxab023</DOI>
    <kwrd>AI/AN, American Indian/Alaska Native</kwrd>
    <kwrd> CRA, caries risk assessment</kwrd>
    <kwrd> DHAT, dental health aide therapist</kwrd>
    <kwrd> DT, dental therapist</kwrd>
    <kwrd> ECC, early childhood caries</kwrd>
    <kwrd> FN, First Nations</kwrd>
    <kwrd> GA, general anesthesia</kwrd>
    <kwrd> IHS, Indian Health Services</kwrd>
    <kwrd> RCT, randomized controlled trial</kwrd>
    <kwrd> SDF, silver diamine fluoride</kwrd>
    <kwrd> S-ECC, severe ECC</kwrd>
  </statement>
  <statement>
    <name>Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity</name>
    <shortlink>adrenal-suppression</shortlink>
    <posted>15-Jun-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-Jun-21</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/pxab015</DOI>
    <kwrd>Adrenal insufficiency</kwrd>
    <kwrd>Adrenal suppression</kwrd>
    <kwrd>Glucocorticoids</kwrd>
    <kwrd>Inhaled corticosteroids (ICS)</kwrd>
  </statement>
  <statement>
    <name>Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: Infant and childhood outcomes</name>
    <shortlink>selective-serotonin</shortlink>
    <posted>29-Jul-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>29-Jul-21</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxab021</DOI>
    <kwrd>Poor neonatal adaptation syndrome</kwrd>
    <kwrd>Pregnancy</kwrd>
    <kwrd>Selective serotonin reuptake inhibitors</kwrd>
    <kwrd>Serotonin-norepinephrine reuptake inhibitors</kwrd>
  </statement>
  <statement>
    <name>Group A streptococcal (GAS) pharyngitis: A practical guide to diagnosis and treatment</name>
    <shortlink>group-a-streptococcal</shortlink>
    <posted>29-Jul-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>29-Jul-21</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxab025</DOI>
    <kwrd>Acute rheumatic fever (ARF)</kwrd>
    <kwrd>Group A Streptococcus (GAS) pharyngitis</kwrd>
    <kwrd>Indigenous children</kwrd>
    <kwrd>Rheumatic heart disease (RHD)</kwrd>
  </statement>
  <statement>
    <name>Clinical guidance for youth with myocarditis and pericarditis following mRNA COVID-19 Vaccination</name>
    <shortlink>clinical-guidance-for-youth-with-myocarditis-and-pericarditis</shortlink>
    <posted>01-Sep-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>16-Sep-21</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI />
    <kwrd>Myocarditis</kwrd>
    <kwrd>pericarditis</kwrd>
    <kwrd>COVID-19 vaccine</kwrd>
    <kwrd>youth</kwrd>
  </statement>
  <statement>
    <name>Assessment, diagnosis, and management of developmental coordination disorder</name>
    <shortlink>developmental-coordination-disorder</shortlink>
    <posted>20-Sep-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Mar-22</changed>
    <Committee>Developmental Paediatrics Section</Committee>
    <DOI>10.1093/pch/pxab047</DOI>
    <kwrd>Developmental coordination disorder</kwrd>
    <kwrd>Diagnosis</kwrd>
    <kwrd>Community paediatrics</kwrd>
  </statement>
  <statement>
    <name>The management of infants, children, and youth at risk for hepatitis C virus (HCV) infection</name>
    <shortlink>the-management-of-hepatitis-c-virus</shortlink>
    <posted>05-Nov-21</posted>
    <Reaffirmed />
    <updated>20-Dec-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>24-Jan-25</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI>10.1093/pch/pxab073</DOI>
    <kwrd>Children</kwrd>
    <kwrd>Direct-acting antivirals (DAAs)</kwrd>
    <kwrd>Hepatitis C virus</kwrd>
    <kwrd>Vertical transmission</kwrd>
  </statement>
  <statement>
    <name>Managing an acute asthma exacerbation in children</name>
    <shortlink>managing-an-acute-asthma-exacerbation</shortlink>
    <posted>05-Nov-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Mar-22</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Paediatric Emergency Medicine Section</Committee>
    <DOI>10.1093/pch/pxab058</DOI>
    <kwrd>Asthma</kwrd>
    <kwrd>Disposition</kwrd>
    <kwrd>Emergency management</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Preschoolers</kwrd>
  </statement>
  <statement>
    <name>The evaluation and management of neonatal brachial plexus palsy </name>
    <shortlink>neonatal-brachial-plexus-palsy</shortlink>
    <posted>03-Dec-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>06-Jan-22</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxab083</DOI>
    <kwrd>Brachial plexus palsy</kwrd>
    <kwrd>Infant</kwrd>
    <kwrd>Neonatal risk</kwrd>
    <kwrd>Neonatal management</kwrd>
    <kwrd>Newborn</kwrd>
  </statement>
  <statement>
    <name>Dietary exposures and allergy prevention in high-risk infants</name>
    <shortlink>dietary-exposures-and-allergy-prevention</shortlink>
    <posted>17-Dec-21</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>06-Jan-22</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <Committee>Allergy Section</Committee>
    <DOI>10.1093/pch/pxab064</DOI>
    <kwrd>Breastfeeding</kwrd>
    <kwrd>Food allergy</kwrd>
    <kwrd>Infants</kwrd>
  </statement>
  <statement>
    <name>Management of the patent ductus arteriosus in preterm infants</name>
    <shortlink>patent-ductus-arteriosus</shortlink>
    <posted>01-Feb-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>24-Mar-22</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <Committee>Drug Therapy Committee</Committee>
    <DOI>10.1093/pch/pxab085</DOI>
    <kwrd>Cyclo-oxygenase inhibitors (COX-I)</kwrd>
    <kwrd>Hemodynamically significant (hs)-PDA</kwrd>
    <kwrd>Patent ductus arteriosus (PDA)</kwrd>
    <kwrd>Preterm infants</kwrd>
    <kwrd>Procedural PDA closure</kwrd>
  </statement>
  <statement>
    <name>Acute complications in children with sickle cell disease: Prevention and management</name>
    <shortlink>acute-complications-with-sickle-cell</shortlink>
    <posted>01-Feb-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>10-Dec-24</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxab096</DOI>
    <kwrd>Hemolytic anemia</kwrd>
    <kwrd>Hemoglobinopathy</kwrd>
    <kwrd>Hydroxyurea</kwrd>
    <kwrd>Newborn screening</kwrd>
  </statement>
  <statement>
    <name>COVID-19 vaccine for children and adolescents</name>
    <shortlink>covid-19-vaccine-for-children-and-adolescents</shortlink>
    <posted>04-Feb-22</posted>
    <Reaffirmed />
    <updated>25-Sep-23</updated>
    <hasupdates>yes</hasupdates>
    <changed>26-Sep-23</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI />
    <kwrd></kwrd>
  </statement>
  <statement>
    <name>Genetic testing and screening in children</name>
    <shortlink>genetic-testing</shortlink>
    <posted>16-Feb-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>19-Jul-22</changed>
    <Committee>Bioethics Committee</Committee>
    <DOI>10.1093/pch/pxac028</DOI>
    <kwrd>Genetic screenings</kwrd>
    <kwrd>Genetic testing</kwrd>
    <kwrd>Paediatrics</kwrd>
  </statement>
  <statement>
    <name>Preventing symptomatic vitamin D deficiency and rickets among Indigenous infants and children in Canada</name>
    <shortlink>vitamin-d-deficiency-and-rickets-among-indigenous-infants-and-children</shortlink>
    <posted>04-Mar-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>19-May-22</changed>
    <Committee>First Nations, Inuit and Métis Health Committee</Committee>
    <DOI>10.1093/pch/pxac003</DOI>
    <kwrd>First Nation</kwrd>
    <kwrd>Hypocalcemia</kwrd>
    <kwrd>Indigenous</kwrd>
    <kwrd>Inuit</kwrd>
    <kwrd>Métis</kwrd>
    <kwrd>Rickets</kwrd>
    <kwrd>Vitamin D deficiency</kwrd>
  </statement>
  <statement>
    <name>Discharge planning of the preterm infant</name>
    <shortlink>discharge-planning-of-the-preterm-infant</shortlink>
    <posted>04-Mar-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>19-May-22</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxac001</DOI>
    <kwrd>Apnea</kwrd>
    <kwrd>Discharge</kwrd>
    <kwrd>Late preterm</kwrd>
    <kwrd>NICU</kwrd>
    <kwrd>Psychosocial</kwrd>
    <kwrd>Thermoregulation</kwrd>
  </statement>
  <statement>
    <name>Umbilical cord management in preterm and term infants</name>
    <shortlink>umbilical-cord-management-in-preterm-and-term-infants</shortlink>
    <posted>15-Mar-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>19-May-22</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1016/j.jogc.2022.01.007</DOI>
    <kwrd></kwrd>
  </statement>
  <statement>
    <name>A call for action: Recommendations to improve transition to adult care for youth with complex health care needs</name>
    <shortlink>transition-to-adult-care-for-youth</shortlink>
    <posted>13-Apr-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>22-Aug-22</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxac047</DOI>
    <kwrd>Adolescent</kwrd>
    <kwrd>Adult Care</kwrd>
    <kwrd>Chronic Illness</kwrd>
    <kwrd>Medical Complexity</kwrd>
    <kwrd>Transfer</kwrd>
    <kwrd>Transition</kwrd>
    <kwrd>Young Adult</kwrd>
    <kwrd>Youth</kwrd>
  </statement>
  <statement>
    <name>Neonatal stabilization in Canada: Updates to Acute Care of at-Risk Newborns (ACoRN) practices and programming</name>
    <shortlink>neonatal-stabilization-in-canada</shortlink>
    <posted>20-May-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>19-May-22</changed>
    <Committee>ACoRN Steering Committee</Committee>
    <DOI />
    <kwrd>Newborn</kwrd>
    <kwrd>Post-resuscitation care</kwrd>
    <kwrd>Stabilization</kwrd>
  </statement>
  <statement>
    <name>Evaluating and optimizing bone health in children with chronic health conditions</name>
    <shortlink>evaluating-and-optimizing-bone-health</shortlink>
    <posted>08-Jul-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>19-Jul-22</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/pxac036</DOI>
    <kwrd>Bone mass accrual</kwrd>
    <kwrd>Fragility fractures</kwrd>
    <kwrd>Preventive bone care</kwrd>
  </statement>
  <statement>
    <name>Vascular anomalies in childhood: When to treat and when to refer</name>
    <shortlink>vascular-anomalies</shortlink>
    <posted>05-Aug-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>22-Aug-22</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/pxac057</DOI>
    <kwrd>Congenital hemangioma</kwrd>
    <kwrd>Infantile hemangioma</kwrd>
    <kwrd>Propranolol</kwrd>
    <kwrd>Vascular anomaly</kwrd>
  </statement>
  <statement>
    <name>Medical neglect: Working with children, youth, and families</name>
    <shortlink>medical-neglect</shortlink>
    <posted>23-Sep-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>05-Oct-22</changed>
    <Committee>Child and Youth Maltreatment Section</Committee>
    <DOI>10.1093/pch/pxac067</DOI>
    <kwrd>Child abuse</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Medical neglect</kwrd>
    <kwrd>Neglect</kwrd>
    <kwrd>Youth</kwrd>
  </statement>
  <statement>
    <name>Follow-up care of the extremely preterm infant after discharge from the neonatal intensive care unit</name>
    <shortlink>follow-up-care</shortlink>
    <posted>23-Sep-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>05-Oct-22</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxac058</DOI>
    <kwrd>Autism spectrum disorder</kwrd>
    <kwrd>Cerebral palsy</kwrd>
    <kwrd>Extremely preterm</kwrd>
    <kwrd>Neurodevelopmental outcomes</kwrd>
    <kwrd>Neurosensory development</kwrd>
  </statement>
  <statement>
    <name>Anxiety in children and youth: Part 1 - Diagnosis</name>
    <shortlink>anxiety-in-children-and-youth-diagnosis</shortlink>
    <posted>20-Oct-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>28-Feb-23</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/pxac102</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>Anxiety disordersh</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Mental health</kwrd>
  </statement>
  <statement>
    <name>Anxiety in children and youth: Part 2 – The management of anxiety disorders</name>
    <shortlink>anxiety-in-children-and-youth-management</shortlink>
    <posted>20-Oct-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>28-Feb-23</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI>10.1093/pch/pxac104</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>Anxiety disordersh</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Mental health</kwrd>
  </statement>
  <statement>
    <name>Best practices in pain assessment and management for children</name>
    <shortlink>pain-assessment-and-management</shortlink>
    <posted>04-Nov-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>09-Dec-22</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Hospital Paediatrics Section</Committee>
    <Committee>Paediatric Emergency Medicine Section</Committee>
    <DOI>10.1093/pch/pxac048</DOI>
    <kwrd>Analgesia</kwrd>
    <kwrd>Assessment</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Pain</kwrd>
    <kwrd>Treatment</kwrd>
  </statement>
  <statement>
    <name>Medical management of gastro-esophageal reflux in healthy infants </name>
    <shortlink>gastro-esophageal-reflux-in-healthy-infants</shortlink>
    <posted>04-Nov-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>04-Nov-22</changed>
    <Committee>Acute Care Committee</Committee>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI />
    <kwrd>Children</kwrd>
    <kwrd>Gastroesophageal reflux (GER)</kwrd>
    <kwrd>Gastroesophageal reflux disease (GERD)</kwrd>
    <kwrd>H2 receptor antagonists (H2RAs)</kwrd>
    <kwrd>Infants</kwrd>
    <kwrd>Prokinetics</kwrd>
    <kwrd>Proton pump inhibitor (PPI)</kwrd>
  </statement>
  <statement>
    <name>Screen time and preschool children: Promoting health and development in a digital world</name>
    <shortlink>screen-time-and-preschool-children</shortlink>
    <posted>24-Nov-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-May-23</changed>
    <Committee>Digital Health Task Force</Committee>
    <DOI>10.1093/pch/pxac125</DOI>
    <kwrd>Development</kwrd>
    <kwrd>Digital media</kwrd>
    <kwrd>Health</kwrd>
    <kwrd>Infant</kwrd>
    <kwrd>Preschool child</kwrd>
    <kwrd>Screen time</kwrd>
  </statement>
  <statement>
    <name>Managing critical drug shortages in clinical practice</name>
    <shortlink>managing-critical-drug-shortages</shortlink>
    <posted>01-Dec-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>10-Jan-23</changed>
    <Committee>Drug Therapy Committee</Committee>
    <DOI />
    <kwrd></kwrd>
  </statement>
  <statement>
    <name>Current recommendations for management of paediatric diabetic ketoacidosis</name>
    <shortlink>current-recommendations-for-management-of-paediatric-diabetic-ketoacidosis</shortlink>
    <posted>05-Dec-22</posted>
    <Reaffirmed />
    <updated></updated>
    <hasupdates>yes</hasupdates>
    <changed>09-May-23</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxac119</DOI>
    <kwrd>Cerebral edema</kwrd>
    <kwrd>Cerebral injury (CI)</kwrd>
    <kwrd>Diabetes mellitus</kwrd>
    <kwrd>Diabetic ketoacidosis (DKA)</kwrd>
    <kwrd>Paediatric</kwrd>
  </statement>
  <statement>
    <name>Using probiotics in paediatric populations</name>
    <shortlink>probiotics-in-paediatric-populations</shortlink>
    <posted>09-Dec-22</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>04-Jan-23</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxac087</DOI>
    <kwrd>Irritable bowel syndrome (IBS)</kwrd>
    <kwrd>Neonates</kwrd>
    <kwrd>Prevention</kwrd>
    <kwrd>Probiotics</kwrd>
  </statement>
  <statement>
    <name>Sport-related concussion and bodychecking in children and youth: Evaluation, management, and policy implications</name>
    <shortlink>sport-related-concussion-and-bodychecking</shortlink>
    <posted>18-Jan-23</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>09-Jun-23</changed>
    <Committee>Injury Prevention Committee</Committee>
    <DOI>10.1093/pch/pxad007</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>Bodychecking</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Concussion</kwrd>
    <kwrd>Return to learn</kwrd>
    <kwrd>Return to play</kwrd>
    <kwrd>Sport</kwrd>
    <kwrd>Youth</kwrd>
  </statement>
  <statement>
    <name>Care considerations for infants born to mothers with suspected or confirmed SARS-CoV-2 infection</name>
    <shortlink>infants-born-to-mothers-with-COVID</shortlink>
    <posted>03-Feb-23</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>03-Feb-23</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI />
    <kwrd></kwrd>
  </statement>
  <statement>
    <name>Inhaled nitric oxide use in newborns</name>
    <shortlink>inhaled-nitric-oxide</shortlink>
    <posted>10-Feb-23</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>09-May-23</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxac107</DOI>
    <kwrd>Hypoxemic respiratory failure</kwrd>
    <kwrd>Inhaled nitric oxide</kwrd>
    <kwrd>Newborn</kwrd>
    <kwrd>Persistent pulmonary hypertension of the newborn</kwrd>
  </statement>
  <statement>
    <name>Gene-based drug therapy in children</name>
    <shortlink>gene-based-drug-therapy-in-children</shortlink>
    <posted>03-Mar-23</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>yes</hasupdates>
    <changed>09-Jun-23</changed>
    <Committee>Drug Therapy and Hazardous Substances Commitee</Committee>
    <DOI>10.1093/pch/pxad002</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>dverse drug reactions</kwrd>
    <kwrd>Child</kwrd>
    <kwrd>Pharmacogenetics</kwrd>
    <kwrd>Pharmacogenomics</kwrd>
  </statement>
  <statement>
    <name>Considerations for privacy and confidentiality in adolescent health care service delivery</name>
    <shortlink>privacy-and-confidentiality-in-adolescent-health-care</shortlink>
    <posted>03-Mar-23</posted>
    <Reaffirmed />
    <updated />
    <hasupdates>no</hasupdates>
    <changed>16-May-23</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxac117</DOI>
    <kwrd>Adolescent</kwrd>
    <kwrd>Confidentiality</kwrd>
    <kwrd>Consent</kwrd>
    <kwrd>Electronic Health Record</kwrd>
    <kwrd>Privacy</kwrd>
  </statement>
  <statement>
    <name>Reducing perinatal infection risk in newborns of mothers who received inadequate prenatal care</name>
    <shortlink>reducing-perinatal-infection-risk-in-newborns-of-mothers-who-received-inadequate-prenatal-care</shortlink>
    <posted>03-Apr-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated>03-Jan-24</updated>
    <hasupdates>yes</hasupdates>
    <changed>09-Apr-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI></DOI>
    <kwrd>Chlamydia</kwrd>
    <kwrd>Gonorrhea</kwrd>
    <kwrd>Hepatitis B</kwrd>
    <kwrd>Hepatitis C</kwrd>
    <kwrd>HIV</kwrd>
    <kwrd>Newborn</kwrd>
    <kwrd>Prenatal care</kwrd>
    <kwrd>Syphilis</kwrd>
  </statement>
  <statement>
    <name>From ACEs to early relational health: Implications for clinical practice</name>
    <shortlink>from-aces-to-early-relational-health</shortlink>
    <posted>03-Apr-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>06-Apr-23</changed>
    <Committee>Early Years Task Force</Committee>
    <DOI>10.1093/pch/pxad025</DOI>
    <kwrd>Adverse childhood experiences</kwrd>
    <kwrd>Child development</kwrd>
    <kwrd>Relational health</kwrd>
    <kwrd>Resilience</kwrd>
    <kwrd>Toxic stress</kwrd>
  </statement>
  <statement>
    <name>Promoting optimal mental health outcomes for children and youth</name>
    <shortlink>promoting-optimal-mental-health-outcomes-for-children-and-youth</shortlink>
    <posted>02-May-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>01-Nov-23</changed>
    <Committee>Mental Health Task Force</Committee>
    <DOI>10.1093/pch/pxad032</DOI>
    <kwrd>Adolescents</kwrd>
    <kwrd>Assessment</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Diagnosis</kwrd>
    <kwrd>Mental health</kwrd>
    <kwrd>Psychoeducation</kwrd>
    <kwrd>Psychotherapy</kwrd>
    <kwrd>Outcomes</kwrd>
    <kwrd>Screening</kwrd>
    <kwrd>Treatment</kwrd>
  </statement>
  <statement>
    <name>Breastfeeding and human milk in the NICU: From birth to discharge</name>
    <shortlink>breastfeeding-and-human-milk-in-the-nicu-from-birth-to-discharge</shortlink>
    <posted>05-Jun-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>yes</hasupdates>
    <changed>23-Apr-24</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxad034</DOI>
    <kwrd>Breastfeeding</kwrd>
    <kwrd>Human milk</kwrd>
    <kwrd>NICU</kwrd>
    <kwrd>Policies</kwrd>
    <kwrd>Preterm</kwrd>
    <kwrd>Skin-to-skin care</kwrd>
    <kwrd>Very low birth weight</kwrd>
  </statement>
  <statement>
    <name>An affirming approach to caring for transgender and gender-diverse youth</name>
    <shortlink>an-affirming-approach-to-caring-for-transgender-and-gender-diverse-youth</shortlink>
    <posted>20-Jun-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>01-Nov-23</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI>10.1093/pch/pxad045</DOI>
    <kwrd>Adolescent</kwrd>
    <kwrd>Gender diverse</kwrd>
    <kwrd>Health</kwrd>
    <kwrd>Hormones</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Transgender</kwrd>
    <kwrd>Youth</kwrd>
  </statement>
  <statement>
    <name>Access to appropriate interpretation is essential for the health of children</name>
    <shortlink>access-to-appropriate-interpretation-is-essential-for-the-health-of-children</shortlink>
    <posted>22-Jun-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>23-Apr-24</changed>
    <Committee>Caring for Kids New to Canada Task Force </Committee>
    <DOI>10.1093/pch/pxad054</DOI>
    <kwrd>Children</kwrd>
    <kwrd>Harm</kwrd>
    <kwrd>Interpreter</kwrd>
    <kwrd>Language</kwrd>
  </statement>
  <statement>
    <name>Management of febrile neutropenia in immunocompetent children and youth</name>
    <shortlink>management-of-febrile-neutropenia-in-immunocompetent-children-and-youth</shortlink>
    <posted>29-Jun-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>07-May-24</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxac127</DOI>
    <kwrd>Fever</kwrd>
    <kwrd>Invasive bacterial infection</kwrd>
    <kwrd>Neutropenia</kwrd>
    <kwrd>Paediatric</kwrd>
  </statement>
  <statement>
    <name>Recognizing and addressing atypical growth</name>
    <shortlink>recognizing-and-addressing-atypical-growth</shortlink>
    <posted>11-Jul-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>23-Apr-24</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxad057</DOI>
    <kwrd>Growth patterns</kwrd>
    <kwrd>Management</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Screening</kwrd>
  </statement>
  <statement>
    <name>Evaluation and management of enuresis in the general paediatric setting</name>
    <shortlink>evaluation-and-management-of-enuresis-in-the-general-paediatric-setting</shortlink>
    <posted>16-Aug-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>16-Aug-23</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI>10.1093/pch/pxad023</DOI>
    <kwrd>Desmopressin</kwrd>
    <kwrd>Enuresis alarms</kwrd>
    <kwrd>Monosymptomatic enuresis (MSE)</kwrd>
    <kwrd>Non-monosymptomatic enuresis (NMSE)</kwrd>
    <kwrd>Primary enuresis</kwrd>
    <kwrd>Secondary enuresis</kwrd>
  </statement>
  <statement>
    <name>Care for children and youth with cerebral palsy (GMFCS levels III to V)</name>
    <shortlink>care-for-children-and-youth-with-cerebral-palsy</shortlink>
    <posted>29-Sep-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>20-Aug-24</changed>
    <Committee>Developmental Paediatrics Section</Committee>
    <DOI>10.1093/pch/pxae003</DOI>
    <kwrd>Anticipatory guidance</kwrd>
    <kwrd>Cerebral palsy</kwrd>
    <kwrd>Early detection</kwrd>
    <kwrd>Surveillance</kwrd>
  </statement>
  <statement>
    <name>Medical cannabis for children: Evidence and recommendations</name>
    <shortlink>medical-cannabis-for-children-evidence-and-recommendations</shortlink>
    <posted>19-Oct-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>19-Oct-23</changed>
    <Committee>Drug Therapy Committee</Committee>
    <DOI>10.1093/pch/pxad078</DOI>
    <kwrd>Cannabinoids</kwrd>
    <kwrd>CBD</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>delta-9-tetrahydrocannabinol</kwrd>
    <kwrd>Medical cannabis</kwrd>
    <kwrd>Pharmacotherapy</kwrd>
  </statement>
  <statement>
    <name>Management of well-appearing febrile young infants aged ≤90 days</name>
    <shortlink>management-of-well-appearing-febrile-young-infants-aged-90-days</shortlink>
    <posted>27-Oct-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>yes</hasupdates>
    <changed>23-Apr-24</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI>10.1093/pch/pxad085</DOI>
    <kwrd>Fever</kwrd>
    <kwrd>Invasive bacterial infection</kwrd>
    <kwrd>Risk-stratification</kwrd>
    <kwrd>Serious bacterial infection</kwrd>
  </statement>
  <statement>
    <name>Recognizing and responding to children with suspected exposure to intimate partner violence between caregivers</name>
    <shortlink>recognizing-and-responding-to-children-with-suspected-exposure-to-intimate-partner-violence-between-caregivers</shortlink>
    <posted>14-Nov-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>20-Aug-24</changed>
    <Committee>Child and Youth Maltreatment Section</Committee>
    <DOI>10.1093/pch/pxad079</DOI>
    <kwrd>Child exposure to intimate partner violence</kwrd>
    <kwrd>Child welfare</kwrd>
    <kwrd>Clinical guidance</kwrd>
    <kwrd>Intimate partner violence</kwrd>
    <kwrd>Trauma-and violence-informed care</kwrd>
  </statement>
  <statement>
    <name>COVID-19 vaccine for children and adolescents: Technical report</name>
    <shortlink>covid-19-vaccine-for-children-and-adolescents-technical-report</shortlink>
    <posted>24-Nov-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>24-Nov-23</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI></DOI>
    <kwrd></kwrd>
  </statement>
  <statement>
    <name>The management of very mild and mild asthma in preschoolers, children, and adolescents</name>
    <shortlink>mild-asthma</shortlink>
    <posted>08-Dec-23</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>23-Apr-24</changed>
    <Committee></Committee>
    <DOI>10.1093/pch/pxae006</DOI>
    <kwrd>Asthma</kwrd>
    <kwrd>Canadian Thoracic Societya</kwrd>
    <kwrd>Mild asthma</kwrd>
    <kwrd>Very mild asthma</kwrd>
  </statement>
  <statement>
    <name>Skin-to-skin care (SSC) for term and preterm infants</name>
    <shortlink>skin-to-skin-care</shortlink>
    <posted>11-Jan-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>20-Ayg-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI>10.1093/pch/pxae015</DOI>
    <kwrd>Breastfeedinge</kwrd>
    <kwrd>Kangaroo care</kwrd>
    <kwrd>Neurodevelopment</kwrd>
    <kwrd>Skin-to-skin care</kwrd>
  </statement>
  <statement>
    <name>Healthy childhood development through outdoor risky play: Navigating the balance with injury prevention</name>
    <shortlink>outdoor-risky-play</shortlink>
    <posted>25-Jan-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>20-Aug-24</changed>
    <Committee>Injury Prevention Committee</Committee>
    <DOI>10.1093/pch/pxae016</DOI>
    <kwrd>Active living</kwrd>
    <kwrd>Children</kwrd>
    <kwrd>Injury</kwrd>
    <kwrd>Play</kwrd>
    <kwrd>Risk</kwrd>
  </statement>
  <statement>
    <name>Gene-based drug therapy for children and youth treated with psychoactive medications</name>
    <shortlink>gene-based-drug-testing-psychoactive-meds</shortlink>
    <posted>14-Feb-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>01-Nov-24</changed>
    <Committee>Drug Therapy Committee</Committee>
    <DOI>10.1093/pch/pxae029</DOI>
    <kwrd>Child psychiatry</kwrd>
    <kwrd>Child and youth mental health</kwrd>
    <kwrd>Pharmacogenetic testing</kwrd>
    <kwrd>Precision medicine</kwrd>
  </statement>
  <statement>
    <name>Goals of care conversations and advance care planning for paediatric patients living with serious illness</name>
    <shortlink>advance-care-planning</shortlink>
    <posted>07-Mar-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>11-Mar-24</changed>
    <Committee>Bioethics Committee</Committee>
    <DOI>10.1093/pch/pxae041</DOI>
    <kwrd>Advance care planning</kwrd>
    <kwrd>Goals of care</kwrd>
    <kwrd>Palliative care</kwrd>
    <kwrd>Serious illness</kwrd>
    <kwrd>Shared decision-making</kwrd>
  </statement>
  <statement>
    <name>Diagnosis and management of congenital syphilis – Avoiding missed opportunities </name>
    <shortlink>congenital-syphilis</shortlink>
    <posted>28-Mar-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>28-Mar-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI></DOI>
    <kwrd>Penicillin</kwrd>
    <kwrd>Pregnancy</kwrd>
    <kwrd>Serology</kwrd>
    <kwrd>Syphilis</kwrd>
  </statement>
  <statement>
    <name>Improving cycling safety for children and youth</name>
    <shortlink>cycling-safety</shortlink>
    <posted>02-May-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>01-Nov-24</changed>
    <Committee>Injury Prevention Committee</Committee>
    <DOI>10.1093/pch/pxae035</DOI>
    <kwrd>Built environment</kwrd>
    <kwrd>Cycling</kwrd>
    <kwrd>Head injury</kwrd>
    <kwrd>Helmet</kwrd>
    <kwrd>Injury prevention</kwrd>
  </statement>
  <statement>
    <name>A guide to the community management of paediatric eating disorders</name>
    <shortlink>eating-disorders</shortlink>
    <posted>06-Jun-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>18-Jun-24</changed>
    <Committee>Adolescent Health Committee</Committee>
    <DOI></DOI>
    <kwrd>Anorexia</kwrd>
    <kwrd>Eating Disorder</kwrd>
    <kwrd>Family-based Treatment</kwrd>
  </statement>
  <statement>
    <name>Cow’s milk protein allergy in infants and children</name>
    <shortlink>cows-milk-protein-allergy</shortlink>
    <posted>25-Jun-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>25-Jun-24</changed>
    <Committee>Nutrition and Gastroenterology Committee</Committee>
    <DOI>10.1093/pch/pxae043</DOI>
    <kwrd>Amino acid formula (AAF)</kwrd>
    <kwrd>Cow’s milk intolerance (CMI)</kwrd>
    <kwrd>Cow’s milk protein allergy (CMPA)</kwrd>
    <kwrd>Extensively hydrolyzed formula (eHF)</kwrd>
    <kwrd>Food protein-induced allergic proctocolitis (FPIAP)</kwrd>
    <kwrd>Food protein-induced enterocolitis syndrome (FPIES)</kwrd>
    <kwrd>Food protein-induced enteropathy (FPE)</kwrd>
    <kwrd>Oral food challenge (OFC)</kwrd>
  </statement>
  <statement>
    <name>Medical assessment of suspected traumatic head injury due to child maltreatment (THI-CM)</name>
    <shortlink>medical-assessment-of-THI-CM</shortlink>
    <posted>18-Jul-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>18-Jul-24</changed>
    <Committee>Child and Youth Maltreatment Section</Committee>
    <DOI></DOI>
    <kwrd>Abusive head trauma</kwrd>
    <kwrd>Child abuse</kwrd>
    <kwrd>Traumatic head injury due to child maltreatment (THI-CM)</kwrd>
  </statement>
  <statement>
    <name>Vaccine recommendations for children and youth for the 2024/2025 influenza season </name>
    <shortlink>vaccine-recommendations-for-children-and-youth-for-the-2024-2025-influenza-season</shortlink>
    <posted>20-Sep-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>20-Sep-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI></DOI>
    <kwrd>Children</kwrd>
    <kwrd>Inactivated influenza vaccine</kwrd>
    <kwrd>Influenza vaccine</kwrd>
    <kwrd>LAIV</kwrd>
    <kwrd>NACI</kwrd>
  </statement>
  <statement>
    <name>Evaluating and caring for children with a suspected learning disorder in community practice </name>
    <shortlink>learning-disorder</shortlink>
    <posted>01-Oct-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>02-Oct-24</changed>
    <Committee>Community Paediatrics Committee</Committee>
    <DOI></DOI>
    <kwrd>Learning challenges</kwrd>
    <kwrd>Specific learning disorder (SLD)</kwrd>
  </statement>
  <statement>
    <name>Literacy in school-aged children: A paediatric approach to advocacy and assessment</name>
    <shortlink>literacy-in-school-aged-children</shortlink>
    <posted>23-Oct-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>22-Oct-24</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI></DOI>
    <kwrd>Evidence-based reading instruction</kwrd>
    <kwrd>Literacy</kwrd>
    <kwrd>Screening</kwrd>
  </statement>
  <statement>
    <name>Respiratory syncytial virus (RSV) prevention strategies for the 2024-2025 viral respiratory illness season</name>
    <shortlink>rsv-prevention-2024-2025</shortlink>
    <posted>06-Nov-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>07-Nov-24</changed>
    <Committee>Infectious Diseases and Immunization Committee</Committee>
    <DOI></DOI>
    <kwrd>Infants</kwrd>
    <kwrd>National Advisory Committee on Immunization (NAC)</kwrd>
    <kwrd>Respiratory syncytial virus (RSV)</kwrd>
    <kwrd>RSV monoclonal antibody</kwrd>
    <kwrd>RSV vaccine</kwrd>
  </statement>
  <statement>
    <name>Somatic symptom and related disorders: Guidance on assessment and management for paediatric health care providers</name>
    <shortlink>somatic-symptom-and-related-disorders</shortlink>
    <posted>20-Nov-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>20-Nov-24</changed>
    <Committee>Mental Health and Developmental Disabilities Committee</Committee>
    <DOI></DOI>
    <kwrd>Conversion disorder</kwrd>
    <kwrd>Functional neurological symptom disorder</kwrd>
    <kwrd>Mind-body</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Somatization</kwrd>
  </statement>
  <statement>
    <name>Managing pain in newborns: A multidimensional approach</name>
    <shortlink>managing-pain-in-newborns</shortlink>
    <posted>18-Dec-24</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>18-Dec-24</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI></DOI>
    <kwrd>Guidelines</kwrd>
    <kwrd>Management</kwrd>
    <kwrd>Neonates</kwrd>
    <kwrd>Pain</kwrd>
    <kwrd>Prevention</kwrd>
  </statement>
  <statement>
    <name>Managing newborns at risk for neonatal abstinence syndrome (NAS)/neonatal opioid withdrawal syndrome (NOWS): Updates and emerging best practices</name>
    <shortlink>nas-nows</shortlink>
    <posted>07-Jan-25</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>13-Jan-25</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI></DOI>
    <kwrd>Eat Sleep Console (ESC)</kwrd>
    <kwrd>Discharge planning</kwrd>
    <kwrd>Neonatal abstinence syndrome (NAS)</kwrd>
    <kwrd>Neonatal opioid withdrawal syndrome (NOWS)</kwrd>
    <kwrd>Opioid-exposed newborn</kwrd>
    <kwrd>Substance-exposed newborn</kwrd>
    <kwrd>Substance-exposed pregnancy (SEP)</kwrd>
    <kwrd>Trauma-informed care (TIC)</kwrd>
  </statement>
  <statement>
    <name>Off-road vehicle use by children and adolescents: Strategies to prevent injury</name>
    <shortlink>off-road-vehicle-use</shortlink>
    <posted>24-Feb-25</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>24-Feb-25</changed>
    <Committee>Injury Prevention Committee</Committee>
    <DOI></DOI>
    <kwrd>All-terrain vehicle (ATV)</kwrd>
    <kwrd>Injury</kwrd>
    <kwrd>A Off-road vehicle (ORV)</kwrd>
    <kwrd>Paediatrics</kwrd>
    <kwrd>Prevention</kwrd>
  </statement>
  <statement>
    <name>Guidelines for detection and management of hyperbilirubinemia in term and late preterm newborns (≥35 weeks gestational age)</name>
    <shortlink>hyperbilirubinemia-newborns</shortlink>
    <posted>18-Mar-25</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>18-Mar-25</changed>
    <Committee>Fetus and Newborn Committee</Committee>
    <DOI></DOI>
    <kwrd>Bilirubin</kwrd>
    <kwrd>Exchange transfusion</kwrd>
    <kwrd>Hemolysis</kwrd>
    <kwrd>Hyperbilirubinemiarapy</kwrd>
    <kwrd>Jaundice</kwrd>
    <kwrd>Neonates</kwrd>
    <kwrd>Phototherapy</kwrd>
  </statement>
  <statement>
    <name>Management of the paediatric patient with acute head trauma</name>
    <shortlink>acute-head-trauma</shortlink>
    <posted>28-Mar-25</posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed>28-Mar-25</changed>
    <Committee>Acute Care Committee</Committee>
    <DOI></DOI>
    <kwrd>Acute head trauma (AHT)</kwrd>
    <kwrd>Computed tomography (CT) scan)</kwrd>
    <kwrd>Prevention</kwrd>
    <kwrd>Skull x-rays</kwrd>
    <kwrd>Traumatic brain injury (TBI)</kwrd>
  </statement>
  <?ignore
  <statement>
    <name></name>
    <shortlink></shortlink>
    <posted></posted>
    <Reaffirmed></Reaffirmed>
    <updated></updated>
    <hasupdates>no</hasupdates>
    <changed></changed>
    <Committee></Committee>
    <DOI></DOI>
    <kwrd></kwrd>
  </statement>
  ?>
</root>
